Disability News and Research

RSS

It's true! study confirms that Glucosamine and Chondroitin relieve arthritis pain

The millions of Osteoarthritis sufferers in the world will welcome the good news that a new study has confirmed that the dietary supplements glucosamine and chondroitin provide pain relief.

15 Nov 2005

Speed of PSA increase matters more than PSA level

In the largest study of its kind to date, Mayo Clinic researchers report that prostate specific antigen (PSA) kinetics, both velocity and doubling time, can be used to predict disease progression and likelihood of death after radical prostatectomy surgery, suggesting that this could be used to guide treatment decisions.

14 Nov 2005

Prevalence of major psychiatric disorders is as common in cancer patients

The prevalence of major psychiatric disorders is as common in cancer patients as they are in the general population, with the exception of panic disorder which had elevated rates compared to the general population (5 percent versus 1.7 percent, respectively).

14 Nov 2005

Human umbilical cord blood cells may widen treatment window for stroke

An experimental treatment that spares disability from acute stroke may be delivered much later than the current three-hour treatment standard – a potential advance needed to benefit more stroke victims.

13 Nov 2005

Use of traction to help treat low back pain has no benefit

"Traction was introduced before it was properly evaluated in high-quality randomized trials, and as an intervention is already part of usual practice,” said lead author Judy M.A. Clarke, M.D. “It is hard to convince health care providers not to use it."

10 Nov 2005

Mental illness exacts "enormous toll" for U.S. businesses

A study led by a Johns Hopkins University School of Medicine psychiatrist highlights the toll anxiety and depressive disorders exact on workplace performance and profits and points to employer-guaranteed specialized psychiatric care as both cost effective and humane.

10 Nov 2005

One in five Americans has or is at serious risk for developing diabetes

At least one in five Americans has or is at serious risk for developing diabetes, meaning millions are at an increased risk for cardiovascular disease, key health organizations are warning.

8 Nov 2005

Statin drug reverses learning and attention deficits in a mouse model of the genetic disorder Neurofibromatosis type I

This week, researchers report evidence that a statin drug already shown to be safe for use in humans has proven effective at correcting cell-cell communication and curing learning disfunction in a mouse model of Neurofibromatosis type I, a human genetic disorder that causes learning disabilities in millions of people worldwide.

7 Nov 2005

Genetic link to dyslexia

About five million Germans have serious learning difficulties when it comes to reading and writing. It is frequently the case that several members of the same family are affected. So hereditary disposition seems to play an important role in the occurrence of dyslexia.

7 Nov 2005

Exercise is good for multiple sclerosis, but it must be done correctly

Aerobic exercise is thought to help persons with multiple sclerosis fight fatigue, the most common symptom of the disease. Yet MS also appears to cause the body to heat up more quickly, compromising the ability to exercise.

3 Nov 2005

Study shows impact of birth order on maternal feelings of excessive concern

New research presented at the 70th Annual Scientific Meeting of the American College of Gastroenterology suggests that birth order impacts child perceptions of maternal solicitousness toward GI symptoms, particularly in families where the mother has Irritable Bowel Syndrome (IBS).

1 Nov 2005

INTERACT trial to look at effects of early intensive blood pressure lowering on death and disability in stroke patients

A large clinical trial called INTERACT, launched in China this month, will determine the effects of early intensive blood pressure lowering on death and disability in stroke patients.

1 Nov 2005

Botox not just for glamour, great for stroke victims too

Botox, or botulinum toxin's, main claim to fame currently seems to be associated with stars and others who wish for fuller lips and ironed out wrinkles, but the treatment does in fact have a far more credible and worthwhile reputation which continues to grow.

1 Nov 2005

Increased physical activity may strenghten adult joint cartilage

Osteoarthritis (OA) is the leading cause of disability among adults. As the population ages, increased intervention efforts are vital to controlling the individual and public health toll of this chronic, crippling joint disease.

30 Oct 2005

DCDC2 gene linked to dyslexia

Pediatric researchers at Yale School of Medicine have identified a gene on human chromosome 6 called DCDC2, which is linked to dyslexia, a reading disability affecting millions of children and adults.

30 Oct 2005

First long-term study to evaluate repeated treatment with BoNTA for post-stroke spasticity

New research shows that repeated treatments of botulinum toxin type A (BoNTA) over one year after a stroke can improve muscle tone and reduce pain in the arms and hands, making it easier for patients to dress themselves and perform personal hygiene.

30 Oct 2005

Math Learning Disorder (LD) is common among school-age children

Results show that boys are more likely to have Math LD than girls. The research also indicates that although a child can have a Math LD and a reading LD, a substantial percentage of children have Math LD alone.

27 Oct 2005

Depression raises disability risk

Depressed middle-aged adults are at four times greater risk for being unable to perform everyday tasks than their non-depressed peers, a Northwestern University study found.

25 Oct 2005

Research has important implications for autism

New research from Melbourne's Howard Florey Institute helps to explain why children with autism spectrum disorders (autism) have problem-solving difficulties.

24 Oct 2005

No credible evidence behind claims of harm from the MMR vaccination

There was no credible evidence behind claims of harm from the MMR vaccination. This is the conclusion drawn by the Cochrane Review Authors, an international team of researchers, after carefully drawing together all of the evidence found in 31 high quality studies from around the world.

18 Oct 2005